These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 23164454)

  • 1. Chronic valproate attenuates some, but not all, facets of mania-like behaviour in mice.
    van Enkhuizen J; Geyer MA; Kooistra K; Young JW
    Int J Neuropsychopharmacol; 2013 Jun; 16(5):1021-31. PubMed ID: 23164454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine transporter knockdown mice in the behavioral pattern monitor: A robust, reproducible model for mania-relevant behaviors.
    Kwiatkowski MA; Hellemann G; Sugar CA; Cope ZA; Minassian A; Perry W; Geyer MA; Young JW
    Pharmacol Biochem Behav; 2019 Mar; 178():42-50. PubMed ID: 29289701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mania-like exploratory profile in genetic dopamine transporter mouse models is diminished in a familiar environment and reinstated by subthreshold psychostimulant administration.
    Young JW; Goey AK; Minassian A; Perry W; Paulus MP; Geyer MA
    Pharmacol Biochem Behav; 2010 Jul; 96(1):7-15. PubMed ID: 20363246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine depletion attenuates some behavioral abnormalities in a hyperdopaminergic mouse model of bipolar disorder.
    van Enkhuizen J; Geyer MA; Halberstadt AL; Zhuang X; Young JW
    J Affect Disord; 2014 Feb; 155():247-54. PubMed ID: 24287168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GBR 12909 administration as a mouse model of bipolar disorder mania: mimicking quantitative assessment of manic behavior.
    Young JW; Goey AK; Minassian A; Perry W; Paulus MP; Geyer MA
    Psychopharmacology (Berl); 2010 Feb; 208(3):443-54. PubMed ID: 20020109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased risk-taking behavior in dopamine transporter knockdown mice: further support for a mouse model of mania.
    Young JW; van Enkhuizen J; Winstanley CA; Geyer MA
    J Psychopharmacol; 2011 Jul; 25(7):934-43. PubMed ID: 21421642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brexpiprazole reduces hyperactivity, impulsivity, and risk-preference behavior in mice with dopamine transporter knockdown-a model of mania.
    Milienne-Petiot M; Geyer MA; Arnt J; Young JW
    Psychopharmacology (Berl); 2017 Mar; 234(6):1017-1028. PubMed ID: 28160035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mood stabilizer valproic acid opposes the effects of dopamine on circadian rhythms.
    Landgraf D; Joiner WJ; McCarthy MJ; Kiessling S; Barandas R; Young JW; Cermakian N; Welsh DK
    Neuropharmacology; 2016 Aug; 107():262-270. PubMed ID: 27033596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic nicotine, but not suramin or resveratrol, partially remediates the mania-like profile of dopamine transporter knockdown mice.
    Kwiatkowski MA; Roberts BZ; van Enkhuizen J; Ji B; Zhou X; Young JW
    Eur Neuropsychopharmacol; 2021 Jan; 42():75-86. PubMed ID: 33191077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling bipolar disorder in mice by increasing acetylcholine or dopamine: chronic lithium treats most, but not all features.
    van Enkhuizen J; Milienne-Petiot M; Geyer MA; Young JW
    Psychopharmacology (Berl); 2015 Sep; 232(18):3455-67. PubMed ID: 26141192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the dopamine transporter as an animal model of bipolar disorder mania: Locomotor response, neuroimmunological profile and pharmacological modulation.
    Bastos JR; Perico KM; Marciano Vieira ÉL; Teixeira AL; Machado FS; de Miranda AS; Moreira FA
    J Psychiatr Res; 2018 Jul; 102():142-149. PubMed ID: 29656188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of dopamine D
    Milienne-Petiot M; Groenink L; Minassian A; Young JW
    J Psychopharmacol; 2017 Oct; 31(10):1334-1346. PubMed ID: 28950781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced dopamine transporter functioning induces high-reward risk-preference consistent with bipolar disorder.
    van Enkhuizen J; Henry BL; Minassian A; Perry W; Milienne-Petiot M; Higa KK; Geyer MA; Young JW
    Neuropsychopharmacology; 2014 Dec; 39(13):3112-22. PubMed ID: 25005251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A reverse-translational study of dysfunctional exploration in psychiatric disorders: from mice to men.
    Perry W; Minassian A; Paulus MP; Young JW; Kincaid MJ; Ferguson EJ; Henry BL; Zhuang X; Masten VL; Sharp RF; Geyer MA
    Arch Gen Psychiatry; 2009 Oct; 66(10):1072-80. PubMed ID: 19805697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of reduced dopamine transporter function and chronic lithium on motivation, probabilistic learning, and neurochemistry in mice: Modeling bipolar mania.
    Milienne-Petiot M; Kesby JP; Graves M; van Enkhuizen J; Semenova S; Minassian A; Markou A; Geyer MA; Young JW
    Neuropharmacology; 2017 Feb; 113(Pt A):260-270. PubMed ID: 27732870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic antipsychotic treatment exerts limited effects on the mania-like behavior of dopamine transporter knockdown mice.
    Cope ZA; Kenton JA; Minassian A; Martin MV; Perry W; Bundgaard C; Arnt J; van Enkhuizen J; Geyer MA; Young JW
    Behav Brain Res; 2021 May; 405():113167. PubMed ID: 33577882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in striatal dopamine transporters in bipolar disorder and valproate treatment.
    Hsueh YS; Lin CY; Chiu NT; Yang YK; Chen PS; Chang HH
    Eur Psychiatry; 2021 Jan; 64(1):e9. PubMed ID: 33413711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valproate attenuates hyperactive and perseverative behaviors in mutant mice with a dysregulated dopamine system.
    Ralph-Williams RJ; Paulus MP; Zhuang X; Hen R; Geyer MA
    Biol Psychiatry; 2003 Feb; 53(4):352-9. PubMed ID: 12586455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimanic activity of minocycline in a GBR12909-induced model of mania in mice: Possible role of antioxidant and neurotrophic mechanisms.
    de Queiroz AIG; Chaves Filho AJM; Araújo TDS; Lima CNC; Machado MJS; Carvalho AF; Vasconcelos SMM; de Lucena DF; Quevedo J; Macedo D
    J Affect Disord; 2018 Jan; 225():40-51. PubMed ID: 28783519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amphetamine increases activity but not exploration in humans and mice.
    Minassian A; Young JW; Cope ZA; Henry BL; Geyer MA; Perry W
    Psychopharmacology (Berl); 2016 Jan; 233(2):225-33. PubMed ID: 26449721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.